Clinical significance of elevation of serum CA125 level in patients with metastatic bladder carcinoma
Objective: To explore the clinical significance of the examination of serum CA125 level of patients with metastatic bladder carcinoma. Methods: Electrochemiluminescence technique was used to examine the serum CA125 concentration of 58 cases with metastatic bladder cancer. 30 cases of superficial bla...
Saved in:
Published in | The Chinese-German journal of clinical oncology Vol. 7; no. 8; pp. 477 - 479 |
---|---|
Main Authors | , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Berlin/Heidelberg
Springer-Verlag
2008
Department of Urology, Dalian Friendship Hospital, Dalian 116001, China%Central Laboratory, Dalian Friendship Hospital, Dalian 116001, China |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Summary: | Objective: To explore the clinical significance of the examination of serum CA125 level of patients with metastatic bladder carcinoma. Methods: Electrochemiluminescence technique was used to examine the serum CA125 concentration of 58 cases with metastatic bladder cancer. 30 cases of superficial bladder cancer and 8 cases of other urological diseases were collected as the control group. Results: Serum CA125 level in 39 (67.2%) out of 58 cases ranged from 36.7 U/mL to 1485.6 U/mL (mean 496.3 U/mL), being higher than normal (〈 35 U/mL). Serum CA125 level of metastatic bladder cancer patients was 324.5 U/mL, significantly higher than that in control group (P 〈 0.001). Serum CA125 level of 10 patients after transurethral resection operation was significantly lower than that before operation (P 〈 0.05). Serum CA125 level of 16 patients who refused further treatment significantly increased from 450.4 U/mL, to 505.8 U/mL (P = 0.041) 3 months after discharge from the hospital. Serum CA125 level of 17 patients significantly decreased from 475.8 U/L to 237.9 U/mL (P 〈 0.001 ) after bilateral iliac-artedal embolism treatment. Conclusion: CA125 may be a valuable marker for the judgment of advanced metastatic bladder cancer. |
---|---|
Bibliography: | bladder neoplasms bladder neoplasms; carcinoma; CA125 antigen R737.14 carcinoma CA125 antigen 42-1654/R |
ISSN: | 1610-1979 1613-9089 |
DOI: | 10.1007/s10330-008-0051-x |